The α7 Nicotinic Agonist ABT-126 in the Treatment of Cognitive Impairment Associated with Schizophrenia in Nonsmokers: Results from a Randomized Controlled Phase 2b Study.
about
Pharmacokinetic Limitations on Effects of an Alpha7 Nicotinic Receptor Agonist in Schizophrenia: Randomized Trial with an Extended Release Formulation.The impact of genetics on future drug discovery in schizophrenia.Placebo Response and Practice Effects in Schizophrenia Cognition Trials.Pharmacological Augmentation of Psychosocial and Remediation Training Efforts in Schizophrenia.The current agonists and positive allosteric modulators of α7 nAChR for CNS indications in clinical trials.A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With Schizophrenia.Stimulation of nicotinic acetylcholine alpha7 receptors rescue schizophrenia-like cognitive impairments in rats.Efficacy of different types of cognitive enhancers for patients with schizophrenia: a meta-analysis
P2860
Q38639637-28990114-6140-4DE6-AD6D-9926D600A755Q38682213-B1554347-B82D-4302-A1C2-A489B89BFD81Q38715567-FB261C49-6936-4BDF-A632-5F18D3E1B23CQ42367850-70A3BCE9-89AB-4EF3-9FBD-C4ECB555EDA1Q47127039-EC1855E1-6F43-4FDB-B19A-995E8EE0993CQ47701023-3C6EE9BD-40DC-458F-A70B-91AA14DF765EQ48840774-DE21D0D8-14AC-437D-B397-2FBDE62F715FQ58561523-382CDE2C-6218-4F1C-9E9A-495124371290
P2860
The α7 Nicotinic Agonist ABT-126 in the Treatment of Cognitive Impairment Associated with Schizophrenia in Nonsmokers: Results from a Randomized Controlled Phase 2b Study.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The α7 Nicotinic Agonist ABT-1 ...... zed Controlled Phase 2b Study.
@ast
The α7 Nicotinic Agonist ABT-1 ...... zed Controlled Phase 2b Study.
@en
The α7 Nicotinic Agonist ABT-1 ...... zed Controlled Phase 2b Study.
@nl
type
label
The α7 Nicotinic Agonist ABT-1 ...... zed Controlled Phase 2b Study.
@ast
The α7 Nicotinic Agonist ABT-1 ...... zed Controlled Phase 2b Study.
@en
The α7 Nicotinic Agonist ABT-1 ...... zed Controlled Phase 2b Study.
@nl
prefLabel
The α7 Nicotinic Agonist ABT-1 ...... zed Controlled Phase 2b Study.
@ast
The α7 Nicotinic Agonist ABT-1 ...... zed Controlled Phase 2b Study.
@en
The α7 Nicotinic Agonist ABT-1 ...... zed Controlled Phase 2b Study.
@nl
P2093
P2860
P356
P1476
The α7 Nicotinic Agonist ABT-1 ...... zed Controlled Phase 2b Study.
@en
P2093
P2860
P2888
P304
P356
10.1038/NPP.2016.101
P407
P577
2016-06-20T00:00:00Z
P6179
1000156408